Comparative Study of [^3H]Ramosetron and [^3H]Granisetron Binding in the Cloned Human 5 : Hydroxytryptamine_3 Receptors

この論文にアクセスする

この論文をさがす

著者

    • Ito Hiroyuki ITO Hiroyuki
    • Neuroscience Research, Pharmacology Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

抄録

Characteristics of the binding of [<SUP>3</SUP>H]ramosetron to cloned human 5-hydroxytryptamine<SUB>3</SUB> (5-HT<SUB>3</SUB>) receptors were investigated and directly compared to those of [<SUP>3</SUP>H]granisetron binding. Saturation studies revealed that [<SUP>3</SUP>H]ramosetron labeled more sites with high affinity (K<SUB>d</SUB>=0.15±0.01 nM, B<SUB>max</SUB>=653±30 fmol/mg protein) than [<SUP>3</SUP>H]granisetron (K<SUB>d</SUB>=1.17±0.25 nM, B<SUB>max</SUB>=427±43 fmol/mg protein). Kinetic studies revealed that dissociation of [<SUP>3</SUP>H]ramosetron was slower than that of [<SUP>3</SUP>H]granisetron. These results suggest that ramosetron is a highly potent 5-HT<SUB>3</SUB>-receptor antagonist.

収録刊行物

  • The Japanese journal of pharmacology

    The Japanese journal of pharmacology 78(3), 381-384, 1998-11-01

    The Japanese Pharmacological Society

参考文献:  15件中 1-15件 を表示

被引用文献:  1件中 1-1件 を表示

各種コード

  • NII論文ID(NAID)
    10008681453
  • NII書誌ID(NCID)
    AA00691188
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    00215198
  • NDL 記事登録ID
    4610828
  • NDL 雑誌分類
    ZS51(科学技術--薬学)
  • NDL 請求記号
    Z53-D199
  • データ提供元
    CJP書誌  CJP引用  NDL  J-STAGE 
ページトップへ